[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"biomarker:msi-h":3},{"name":4,"total":5,"recruiting":5,"trials":6},"MSI-H",1,[7],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT06795009","Zanzalintinib in Combination With Paclitaxel in Recurrent High Grade Uterine Cancer",[11],"Phase 1","RECRUITING","2026-08-26T02:16:14.341106Z","2026-05-05T02:43:26.984599Z"]